Plain-English translation of NCT05438563 on ClinicalTrials.gov β Β· Source last updated Β· Translation generated Β· How we translate trials
This study doesn't follow the usual testing phases β it may be an observational study or a different type of research.
This trial is testing a procedure called TULSA (transurethral ultrasound ablation), which uses ultrasound waves guided by MRI imaging to heat and destroy prostate cancer tumors. The treatment is designed for men with early-stage, low to intermediate-grade prostate cancer. Doctors hope this approach offers a way to treat cancer while preserving quality of life and normal function.
Many men with early prostate cancer face a difficult choice between aggressive treatments like surgery or radiation and simply monitoring the cancer. This trial exists to see if TULSA offers a middle groundβa less invasive option that destroys cancer while reducing the side effects that patients often experience with traditional treatments.
You likely qualify ifβ¦
You likely don't qualify ifβ¦
You will receive the TULSA procedure, which involves inserting a small ultrasound device through the urethra (guided by MRI imaging) to treat the cancer. Before the procedure, you may need some screening tests like MRI, biopsies, or imaging scans. After treatment, you'll return for follow-up visits at 3, 6, 9, 12, 15, 18, 21, and 24 months so doctors can monitor your recovery, check for side effects, and assess how well the treatment worked.
AI-generated summary from trial data Β· Aug 12, 2026 Β· Not medical advice
United States